BioSpace News Archive

Antares Pharma, Inc. announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies Virtual Healthcare Conference on Tuesday, June 2, 2020 at 10:00 a.m. Eastern Time.

Codexis, Inc., a leading protein engineering company, announces that management will participate in two virtual investment conferences

Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced that presentations by the management team will be made at the following investor conferences in June: Jefferies Virtual Global Healthcare Conference on June 3, 2020, at 9:00 AM ET Goldman Sachs Virtual Annual Global Healthcare Conference on June 11, 2020, at 11:20 AM ET Live webcasts of the presentations will be available under “News & Ev

Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company dedicated to the development of regenerative therapies, announced a health update for two critically ill COVID-19 patients who were treated at Landmark Hospital in Athens, GA with the Company’s Organicell Flow product.

Lexicon Pharmaceuticals, Inc. announced that Lonnel Coats, President and Chief Executive Officer, will present at the following conference

Synthetic Biologics, Inc. announced that it entered into an agreement with Massachusetts General Hospital granting the Company an option for an exclusive license to intellectual property and technology related to the use of intestinal alkaline phosphatase to maintain GI and microbiome health, diminish systemic inflammation, and treat age-related diseases.

BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical Company focused on oncology, today announced that a paper, entitled ‘BL-8040, a CXCR4 Antagonist, in Combination with Pembrolizumab and Chemotherapy for Pancreatic Cancer: The COMBAT Trial,’ has been published in the peer-reviewed journal Nature Medicine

John Theurer Cancer Center, at Hackensack Meridian Health Hackensack University Medical Center in New Jersey, and Genomic Testing Cooperative, Irvine, CA, announced an agreement to establish a state-of-the-art, next generation sequencing laboratory for molecular profiling.

Findings From Qualitative Patient Substudy Evaluating Health-Related Quality of Life in Patients With Schizophrenia and Treatment Satisfaction, Including Treatment with ALKS 3831, to be Presented

New MONALEESA-7 (M7) and MONALEESA-3 (M3) subgroup analysis to be presented during ASCO20 Virtual Scientific Program